Loveless Wealth Management’s AbbVie ABBV Stock Holding History

Loveless Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3.84M	Sell	25,045 -405	-2%	-$61.9K	2.51%	4
2022 Q1	$4.13M	Sell	25,450 -917	-3%	-$133K	2.33%	7
2021 Q4	$3.57M	Buy	26,367 +459	+2%	+$54.2K	1.96%	10
2021 Q3	$2.79M	Buy	25,908 +38	+0.1%	+$4.34K	1.7%	12
2021 Q2	$2.91M	Buy	25,870 +453	+2%	+$51K	1.77%	12
2021 Q1	$2.75M	Buy	25,417 +465	+2%	+$49.7K	1.82%	11
2020 Q4	$2.67M	Sell	24,952 -72	-0.3%	-$6.92K	1.97%	12
2020 Q3	$2.19M	Sell	25,024 -139	-0.6%	-$13.1K	1.85%	14
2020 Q2	$2.47M	Buy	25,163 +629	+3%	+$55.4K	2.3%	4
2020 Q1	$1.87M	Buy	24,534 +730	+3%	+$62.2K	2.2%	7
2019 Q4	$2.11M	Buy	+23,804	New	+$1.98M	1.82%	9

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Loveless Wealth Management's ABBV Position: Q2 2022 in Review

Loveless Wealth Management reduced its AbbVie (ABBV) stake by 1.6% in Q2 2022, selling an estimated $61.9K and leaving 25,045 shares worth $3.84M. The position accounts for 2.51% of the portfolio, ranked #4.

Loveless Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 11 quarters since. The position peaked at $4.13M in Q1 2022. 3,004 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

Loveless Wealth Management held 25,045 shares of AbbVie worth $3.84M as of Q2 2022.
Loveless Wealth Management sold 405 AbbVie shares in Q2 2022, an estimated $61.9K.
AbbVie made up 2.51% of Loveless Wealth Management's portfolio in Q2 2022, its #4 holding.
Loveless Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 11 quarters since.
Loveless Wealth Management's AbbVie position peaked at $4.13M in Q1 2022.
3,004 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Loveless Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.